Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000072

Drug Information
SynonymsFentanylum; PDSP1_000860; Sublimase; Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI); BRN 0494484; Fentanylum [INN-Latin]; Duragesic-75; CHEMBL596; PDSP2_000846; 5-22-08-00049 (Beilstein Handbook Reference); N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide; BIDD:GT0555; CHEBI:119915; Propanamide, N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-; N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide; Fentanyl (JAN/USAN/INN); Sentonil; N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide; N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide; 437-38-7; 1-Phenethyl-4-N-propionylanilinopiperidine; R 4263; Duragesic; Fentanyl-25; 80832-90-2; Fentanyl-75; Fentanila; Duragesic (TN); LS-124439; Oprea1_207148; Duragesic-25; Fentanil [DCIT]; Fentanyl [INN:BAN]; fentanyl; Nasalfent; Phentanyl; NCGC00168252-01; Duragesic-100; HSDB 3329; N-(1-Phenethyl-4-piperidyl)propionanilide; N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide; 990-73-8 (citrate); N-Phenethyl-4-(N-propionylanilino)piperidine; CID3345; Fentanyl-100; Fentanyl-12; Durogesic; Rapinyl; Oprea1_152073; Propionanilide, N-(1-phenethyl-4-piperidyl)-; N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide; MolPort-003-847-369; Fentanyl-50; Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)-; D00320; Fentanest; Duragesic-12; IONSYS; JNS020QD; UNII-UF599785JZ; Fentanila [INN-Spanish]; L001275; Fentanil; 1-Phenethyl-4-(N-phenylpropionamido)piperidine; Matrifen; AC1L1FQ2; DB00813; Duragesic-50; EINECS 207-113-6    
Trade NameActiq; Duragesic; Fentora; Sublimaze    
CompanyJanssen Pharmaceutica    
IndicationAnestheticApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnesthetics    
CAS NumberCAS 437-38-7
PubChem Compound IDCID 3345.    
PubChem Substance IDSID 153132.    
SuperDrug ATC IDN01AH01;    
SuperDrug CAS ID000437387;    
TargetMu-type opioid receptorAgonist[2]
Ref 1A review of patent literature for iontophoretic delivery and devices. Recent Pat Drug Deliv Formul. 2008;2(1):41-50. To Reference
Ref 2Opioid receptor mechanisms at the hypoglossal motor pool and effects on tongue muscle activity in vivo. J Physiol. 2009 Jun 1;587(Pt 11):2677-92. Epub 2009 Apr 29. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543